Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
TuHURA Biosciences, Inc. (HURA)
USD2.31
-0.07 (-2.94%)
US NASDAQ Healthcare Biotechnology
Address
10500 University Center Drive
Tampa, US
Tampa, US
CEO
James A. Bianco
Website
tuhurabio.com
IPO
2013-02-22
CIK 1498382 ISIN US8989201038
Also trades on
NASDAQ Capital Market · HURA (USD)
NASDAQ Capital Market · KTRA (USD)
Other OTC · DMPWW (USD)
Description
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| KINETA, INC./DE | KANT | 2025-02-07 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD2.31
-0.07 (-2.94%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
903.1K
Beta
-0.04
Float Shares
41.23M
Free Float %
64.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.97% | +0.00% | -20.89% | +104.42% | +22.87% | +205.27% | -38.73% | -20.62% | -96.36% | -99.91% | -99.93% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
2.31
DCF (Unlevered)
0.07
-97.2%
DCF (Levered)
0.07
-97.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | +1 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
4.05
Safe zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+48.1% ★ Q1'26: +13.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-165.2% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+156.8% Q1'26: +38.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.02×
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2014 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 3 EPS Ana. |
Dec 2027 4 Rev. Ana. 2 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
800.0K
est.
|
—
est: 5.00M (-100.0%)
|
—
est: 5.00M (-100.0%)
|
—
est: 19.64M (-100.0%)
|
—
est: 24.30M (-100.0%)
|
—
est: 24.30M (-100.0%)
|
—
est: 7.02M (-100.0%)
|
10.53M
10.53M – 10.53M
+50.0% YoY
|
33.85M
33.85M – 33.85M
+221.3% YoY
|
29.67M
29.67M – 29.67M
-12.3% YoY
|
66.24M
66.24M – 66.24M
+123.3% YoY
|
100.23M
100.23M – 100.23M
+51.3% YoY
|
| EBITDA |
—
est.
|
-11.11M
|
-8.03M
|
-14.74M
|
-8.27M
|
-17.43M
|
-29.36M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
—
est.
|
-11.14M
|
-8.05M
|
-14.80M
|
-8.32M
|
-17.54M
|
-29.43M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-156.77B
est.
|
-11.14M
est: -176.36B (+100.0%)
|
-8.05M
est: -48.17B (+100.0%)
|
-14.65M
est: -13.72B (+99.9%)
|
-8.32M
est: -4.14B (+99.8%)
|
-21.68M
est: -4.14B (+99.5%)
|
-30.06M
est: -29.56M (-1.7%)
|
-22.65M
-25.74M – -19.56M
+23.4% YoY
|
-24.32M
-28.52M – -20.13M
-7.4% YoY
|
-11.04M
-108.45M – 88.73M
+54.6% YoY
|
-6.95M
-6.95M – -6.95M
+37.1% YoY
|
5.99M
5.99M – 5.99M
+186.2% YoY
|
| SGA |
—
est.
|
4.02M
|
4.72M
|
5.43M
|
5.73M
|
4.31M
|
7.58M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-8,400.00
est.
|
-9,491.48
est: -9,450.00 (-0.4%)
|
-5,525.00
est: -2,581.25 (-114.0%)
|
-324.48
est: -735.00 (+55.9%)
|
-11.29
est: -86.45 (+86.9%)
|
-1.21
est: -86.45 (+98.6%)
|
-0.63
est: -0.62 (-2.2%)
|
-0.48
-0.54 – -0.41
+21.6% YoY
|
-0.51
-0.60 – -0.42
-6.2% YoY
|
-0.48
-2.26 – 1.85
+6.5% YoY
|
-0.15
-0.15 – -0.15
+69.8% YoY
|
0.13
0.13 – 0.13
+186.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-13 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
39
Total invested
6.47M
Insider transactions (90d)
0
Beneficial owners (>5%)
29
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vijay Patel | 12.35M | 26.70% | 12.35M | — | 12.35M | 10.00 | IN | United States | 2024-10-25 | ↗ |
| 2 | Jeff Easton | 3.77M | 5.80% | 3.77M | — | 3.77M | — | IN | Delaware | 2022-04-20 | ↗ |
| 3 | Lind Global Fund II LP | 3.77M | 5.80% | 3.77M | — | 3.77M | — | PN | Delaware | 2022-04-20 | ↗ |
| 4 | Lind Global Partners II LLC | 3.77M | 5.80% | 3.77M | — | 3.77M | — | OO | Delaware | 2022-04-20 | ↗ |
| 5 | James A. Bianco, M.D. | 2.70M | 6.40% | 2.70M | — | 2.70M | 10.00 | IN | United States | 2024-10-25 | ↗ |
| 6 | CA Patel F&F Investments, LLC | 2.57M | 6.10% | 2.57M | — | 2.57M | — | OO | United States | 2024-10-25 | ↗ |
| 7 | KP Biotech Group LLC | 2.57M | 6.10% | 2.57M | — | 2.57M | — | OO | United States | 2024-10-25 | ↗ |
| 8 | Charles S. Theofilos, M.D. | 2.51M | 5.90% | 670.9K | 1.84M | 670.9K | — | IN | United States | 2024-10-25 | ↗ |
| 9 | Samir Patel | 2.47M | 5.80% | 2.47M | — | 2.47M | — | IN | United States | 2024-10-25 | ↗ |
| 10 | Donald G. Bahouth | 2.09M | 11.18% | 2.09M | — | — | — | IN | United States of America | 2013-02-01 | ↗ |
| 11 | B. Asher | 2.00M | 8.60% | — | 2.00M | — | 2.00M | HC | States of America | 2017-10-10 | ↗ |
| 12 | Capital LLC | 2.00M | 8.60% | — | 2.00M | — | 2.00M | OO | States of America | 2017-10-10 | ↗ |
| 13 | P. Kopin | 2.00M | 8.60% | — | 2.00M | — | 2.00M | HC | States of America | 2017-10-10 | ↗ |
| 14 | K. Stern | 1.65M | 6.95% | 1.57M | 80.3K | 1.57M | 80.3K | IN | USA | 2020-08-28 | ↗ |
| 15 | Carolyn A. Pilkiewicz | 1.17M | 2.41% | 20.2K | 1.15M | 20.2K | 1.15M | IN | USA | 2022-02-07 | ↗ |
| 16 | Michael B. DeGidio | 1.15M | 2.38% | 4.6K | 1.15M | 4.6K | 1.15M | IN | USA | 2022-02-07 | ↗ |
| 17 | Robert M. Newsome | 1.15M | 6.85% | 1.15M | — | — | — | IN | United State of America | 2013-02-01 | ↗ |
| 18 | The Frank G. Pilkiewicz Revocable Trust dtd 10-17-2001 | 1.15M | 2.37% | — | 1.15M | — | 1.15M | OO | USA | 2022-02-07 | ↗ |
| 19 | Daniel B. Asher | 908.0K | 9.99% | — | 908.0K | — | 892.4K | HC, IN | United States of America | 2019-08-23 | ↗ |
| 20 | Intracoastal Capital LLC | 908.0K | 9.99% | — | 908.0K | — | 892.4K | OO | United States of America | 2019-08-23 | ↗ |
| 21 | Mitchell P. Kopin | 908.0K | 9.99% | — | 908.0K | — | 892.4K | HC, IN | United States of America | 2019-08-23 | ↗ |
| 22 | William Garner, MD | 612.4K | 4.50% | 612.4K | — | 612.4K | — | IN | United States | 2017-06-12 | ↗ |
| 23 | CVI Investments, Inc. | 599.1K | 4.90% | — | 599.1K | — | 599.1K | CO | Cayman Islands | 2020-02-10 | ↗ |
| 24 | Heights Capital Management, Inc. | 599.1K | 4.90% | — | 599.1K | — | 599.1K | CO | Delaware | 2020-02-10 | ↗ |
| 25 | Empery Asset Management, LP | 190.1K | 7.65% | — | 190.1K | — | — | PN | Delaware | 2019-06-05 | ↗ |
| 26 | Martin D. Hoe | 190.1K | 7.65% | — | 190.1K | — | — | IN | United States | 2019-06-05 | ↗ |
| 27 | Ryan M. Lane | 190.1K | 7.65% | — | 190.1K | — | — | IN | United States | 2019-06-05 | ↗ |
| 28 | Family Partners, L.P. | 80.1K | 0.34% | — | 80.1K | — | 80.1K | OO | Nevada | 2020-08-28 | ↗ |
| 29 | Family Foundation | 157.00 | 0.00% | — | 157.00 | — | 157.00 | OO | Nevada | 2020-08-28 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
39
-24 vs prev Q
New positions
12
Closed positions
36
Increased
29
Reduced
4
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 2.32M +50.1K (+2.2%) | 1.76M -3.9M (-68.8%) | 4.58% -0.516 pp | 0.00% 0.000 pp | USD3.15 -75.9% | 5 qtrs — |
| 2 | BLACKROCK, INC. | 1.57M +44.4K (+2.9%) | 1.19M -2.6M (-68.6%) | 3.09% -0.324 pp | 0.00% +0.000 pp | USD2.66 -71.4% | 5 qtrs — |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 662.5K +39.7K (+6.4%) | 501.4K -1.0M (-67.5%) | 1.31% -0.090 pp | 0.00% 0.000 pp | USD2.92 -74.0% | 5 qtrs — |
| 4 | STATE STREET CORP | 289.1K +13.6K (+4.9%) | 218.8K -464.6K (-68.0%) | 0.57% -0.048 pp | 0.00% +0.000 pp | USD2.38 -68.1% | 5 qtrs — |
| 5 | BANK OF NEW YORK MELLON CORP | 210.4K +13.1K (+6.6%) | 159.2K -330.1K (-67.5%) | 0.47% +0.029 pp | 0.00% 0.000 pp | USD2.14 -64.5% | 3 qtrs — |
| 6 | NORTHERN TRUST CORP | 191.6K +4.8K (+2.6%) | 145.0K -318.3K (-68.7%) | 0.38% -0.041 pp | 0.00% +0.000 pp | USD2.71 -72.0% | 5 qtrs — |
| 7 | MORGAN STANLEY | 176.2K +154.4K (+709.9%) | 133.3K +79.4K (+147.1%) | 0.35% +0.299 pp | 0.00% +0.000 pp | USD1.00 -24.0% | 5 qtrs — |
| 8 | APOLLON WEALTH MANAGEMENT, LLC | 134.3K +767.0 (+0.6%) | 101.6K -229.5K (-69.3%) | 0.30% +0.002 pp | 0.00% -0.004 pp | USD3.51 -78.3% | 5 qtrs — |
| 9 | SUNCOAST EQUITY MANAGEMENT | 104.4K +— (+0.0%) | 79.0K -179.9K (-69.5%) | 0.23% +0.000 pp | 0.01% -0.018 pp | USD4.01 -81.0% | 5 qtrs — |
| 10 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 81.9K +2.9K (+3.7%) | 62.0K -134.0K (-68.4%) | 0.16% -0.016 pp | 0.00% +0.000 pp | USD2.52 -69.8% | 5 qtrs — |
| 11 | DEUTSCHE BANK AG\ | 79.8K +54.1K (+209.8%) | 60.7K -3.2K (-5.1%) | 0.18% +0.121 pp | 0.00% +0.000 pp | USD1.23 -38.2% | 3 qtrs — |
| 12 | BANK OF AMERICA CORP /DE/ | 63.0K +55.6K (+748.5%) | 47.6K +29.2K (+158.7%) | 0.12% +0.108 pp | 0.00% +0.000 pp | USD1.13 -32.7% | 5 qtrs — |
| 13 | BARCLAYS PLC | 52.6K +15.7K (+42.6%) | 39.8K -51.7K (-56.5%) | 0.10% +0.021 pp | 0.00% +0.000 pp | USD1.79 -57.5% | 3 qtrs — |
| 14 | INVST, LLC | 42.5K +20.0K (+88.9%) | 32.2K -23.6K (-42.4%) | 0.10% +0.045 pp | 0.00% -0.003 pp | USD1.97 -61.4% | 4 qtrs — |
| 15 | GOLDMAN SACHS GROUP INC | 39.1K +39.1K (+100.0%) | 29.6K +29.6K (+100.0%) | 0.08% +0.077 pp | 0.00% +0.000 pp | USD0.76 +0.0% | 1 qtrs NEW |
| 16 | WELLS FARGO & COMPANY/MN | 38.2K +19.9K (+109.0%) | 28.9K -16.4K (-36.2%) | 0.08% +0.034 pp | 0.00% +0.000 pp | USD1.57 -51.6% | 5 qtrs — |
| 17 | NUVEEN, LLC | 33.6K +— (+0.0%) | 25.4K -57.9K (-69.5%) | 0.07% -0.009 pp | 0.00% +0.000 pp | USD2.23 -65.9% | 3 qtrs — |
| 18 | HURLOW WEALTH MANAGEMENT GROUP, INC. | 31.4K +— (+0.0%) | 23.8K -54.2K (-69.5%) | 0.06% -0.009 pp | 0.01% -0.014 pp | USD4.09 -81.4% | 5 qtrs — |
| 19 | CYNDEO WEALTH PARTNERS, LLC | 31.1K +— (+0.0%) | 23.5K -53.5K (-69.5%) | 0.07% +0.000 pp | 0.00% -0.003 pp | USD3.03 -74.9% | 5 qtrs — |
| 20 | UBS GROUP AG | 28.1K -113.3K (-80.1%) | 21.3K -329.6K (-93.9%) | 0.06% -0.262 pp | 0.00% 0.000 pp | USD2.98 -74.5% | 5 qtrs — |
| 21 | NEW YORK STATE COMMON RETIREMENT FUND | 25.5K +— (+0.0%) | 19.3K -43.9K (-69.5%) | 0.06% +0.000 pp | 0.00% 0.000 pp | USD2.23 -65.9% | 3 qtrs — |
| 22 | RHUMBLINE ADVISERS | 23.6K +1.7K (+7.6%) | 17.9K -36.5K (-67.2%) | 0.05% -0.003 pp | 0.00% +0.000 pp | USD2.13 -64.3% | 3 qtrs — |
| 23 | PFG INVESTMENTS, LLC | 23.4K +3.0 (+0.0%) | 17.7K -40.3K (-69.5%) | 0.05% +0.000 pp | 0.00% -0.002 pp | USD2.48 -69.4% | 2 qtrs — |
| 24 | AQR CAPITAL MANAGEMENT LLC | 16.5K -17.6K (-51.6%) | 12.5K -72.0K (-85.2%) | 0.03% -0.044 pp | 0.00% +0.000 pp | USD2.48 -69.4% | 2 qtrs — |
| 25 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 15.4K +3.7K (+31.9%) | 11.7K -17.4K (-59.8%) | 0.03% +0.004 pp | 0.00% +0.000 pp | USD1.87 -59.4% | 3 qtrs — |
| 26 | MERCK & CO., INC. | 14.0K +— (+0.0%) | 10.6K -24.0K (-69.5%) | 0.03% -0.004 pp | 0.00% -0.011 pp | USD2.23 -65.9% | 3 qtrs — |
| 27 | INVESCO LTD. | 13.8K +272.0 (+2.0%) | 10.4K -23.1K (-68.9%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD2.20 -65.5% | 3 qtrs — |
| 28 | JPMORGAN CHASE & CO | 13.5K +3.2K (+30.7%) | 10.3K -15.5K (-60.1%) | 0.03% +0.007 pp | 0.00% +0.000 pp | USD1.88 -59.6% | 3 qtrs — |
| 29 | PRICE T ROWE ASSOCIATES INC /MD/ | 13.1K +— (+0.0%) | 10.0K -23.0K (-69.7%) | 0.03% -0.004 pp | 0.00% +0.000 pp | USD2.23 -65.9% | 3 qtrs — |
| 30 | INTECH INVESTMENT MANAGEMENT LLC | 10.8K -2.7K (-19.8%) | 8.1K -25.1K (-75.5%) | 0.02% -0.006 pp | 0.00% 0.000 pp | USD2.24 -66.1% | 3 qtrs — |
| 31 | HANCOCK WHITNEY CORP | 10.6K +— (+0.0%) | 8.0K -18.3K (-69.5%) | 0.02% -0.003 pp | 0.00% 0.000 pp | USD2.23 -65.9% | 3 qtrs — |
| 32 | JOURNEY STRATEGIC WEALTH LLC | 10.0K +10.0K (+100.0%) | 7.6K +7.6K (+100.0%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD0.76 +0.0% | 1 qtrs NEW |
| 33 | CWA ASSET MANAGEMENT GROUP, LLC | 10.0K +10.0K (+100.0%) | 7.6K +7.6K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.000 pp | USD0.76 +0.0% | 1 qtrs NEW |
| 34 | HODGES CAPITAL MANAGEMENT INC. | 10.0K +10.0K (+100.0%) | 7.6K +7.6K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.001 pp | USD0.76 +0.0% | 1 qtrs NEW |
| 35 | TT CAPITAL MANAGEMENT LLC | 10.0K +— (+0.0%) | 7.6K -17.2K (-69.5%) | 0.02% +0.000 pp | 0.01% -0.013 pp | USD4.09 -81.4% | 5 qtrs — |
| 36 | TOWER RESEARCH CAPITAL LLC (TRC) | 8.1K +3.7K (+84.8%) | 6.1K -4.7K (-43.6%) | 0.02% +0.006 pp | 0.00% 0.000 pp | USD1.69 -55.0% | 2 qtrs — |
| 37 | BNP PARIBAS ARBITRAGE, SNC | 7.6K +2.0K (+36.1%) | 5.8K -8.1K (-58.5%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD1.90 -60.0% | 3 qtrs — |
| 38 | FMR LLC | 7.5K +5.2K (+233.9%) | 5.7K +104.0 (+1.9%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD1.25 -39.2% | 3 qtrs — |
| 39 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 6.0K +— (+0.0%) | 4.6K -10.4K (-69.5%) | 0.01% -0.002 pp | 0.00% 0.000 pp | USD2.48 -69.4% | 2 qtrs — |
| 40 | STRS OHIO | 4.8K +— (+0.0%) | 3.6K -8.3K (-69.5%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.23 -65.9% | 3 qtrs — |
| 41 | ACCENT CAPITAL MANAGEMENT, LLC | 3.5K -3.5K (-50.0%) | 2.6K -14.7K (-84.7%) | 0.01% -0.009 pp | 0.00% -0.006 pp | USD4.09 -81.4% | 5 qtrs — |
| 42 | ADVISOR GROUP HOLDINGS, INC. | 3.0K -1.3K (-30.5%) | 2.3K -9.3K (-80.4%) | 0.01% -0.004 pp | 0.00% +0.000 pp | USD2.65 -71.3% | 5 qtrs — |
| 43 | LEGAL & GENERAL GROUP PLC | 2.9K +— (+0.0%) | 2.2K -4.9K (-69.5%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.23 -65.9% | 3 qtrs — |
| 44 | AMERITAS INVESTMENT PARTNERS, INC. | 2.6K +— (+0.0%) | 2.0K -4.5K (-69.5%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD2.23 -65.9% | 3 qtrs — |
| 45 | RUSSELL INVESTMENTS GROUP, LTD. | 2.1K -1.1K (-33.8%) | 1.6K -6.4K (-79.8%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD2.48 -69.4% | 2 qtrs — |
| 46 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2.0K +429.0 (+26.7%) | 1.5K -2.4K (-61.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.92 -60.4% | 3 qtrs — |
| 47 | ROYAL BANK OF CANADA | 1.5K +891.0 (+152.3%) | 1.0K +— (+0.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD1.44 -47.2% | 2 qtrs — |
| 48 | AMALGAMATED BANK | 1.0K +167.0 (+19.0%) | 1.0K -1.0K (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.99 -61.8% | 3 qtrs — |
| 49 | CWM, LLC | 1.1K -1.5K (-57.8%) | 1.0K -6.0K (-85.7%) | 0.00% -0.004 pp | 0.00% +0.000 pp | USD2.48 -69.4% | 2 qtrs — |
| 50 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 964.00 +— (+0.0%) | 729.00 -1.7K (-69.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.48 -69.4% | 2 qtrs — |
| 51 | CITIGROUP INC | 752.00 -929.0 (-55.3%) | 569.00 -3.6K (-86.4%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD2.23 -65.9% | 5 qtrs — |
| 52 | FARTHER FINANCE ADVISORS, LLC | 370.00 +— (+0.0%) | 280.00 -638.0 (-69.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.48 -69.4% | 2 qtrs — |
| 53 | GAMMA INVESTING LLC | 341.00 +341.0 (+100.0%) | 258.00 +258.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD0.76 +0.0% | 1 qtrs NEW |
| 54 | NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | 202.00 +— (+0.0%) | 153.00 -348.0 (-69.5%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD2.23 -65.9% | 3 qtrs — |
| 55 | STERLING CAPITAL MANAGEMENT LLC | 167.00 +105.0 (+169.4%) | 126.00 -28.0 (-18.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.30 -41.5% | 3 qtrs — |
| 56 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 100.00 +100.0 (+100.0%) | 76.00 +76.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.75 +1.3% | 1 qtrs NEW |
| 57 | EVERSOURCE WEALTH ADVISORS, LLC | 65.00 -5.0 (-7.1%) | 49.00 -125.0 (-71.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.46 -69.1% | 2 qtrs — |
| 58 | SBI SECURITIES CO., LTD. | 12.00 +9.0 (+300.0%) | 9.00 +2.0 (+28.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.17 -35.0% | 5 qtrs — |
| 59 | PNC FINANCIAL SERVICES GROUP, INC. | 5.00 -422.0 (-98.8%) | 4.00 -1.1K (-99.6%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.40 -68.3% | 2 qtrs — |
| 60 | ALLWORTH FINANCIAL LP | 3.00 +3.0 (+100.0%) | 3.00 +3.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.67 +13.4% | 1 qtrs NEW |
| 61 | IFP ADVISORS, INC | 4.00 -10.0 (-71.4%) | 3.00 -32.0 (-91.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.25 -66.2% | 3 qtrs — |
| 62 | TRUE WEALTH DESIGN, LLC | 2.00 -150.0 (-98.7%) | 2.00 -375.0 (-99.5%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD2.00 -62.0% | 2 qtrs — |
| 63 | NEWEDGE ADVISORS, LLC | 1.00 +— (+0.0%) | 1.00 -1.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 -62.0% | 2 qtrs — |
| 64 | BRIGHTON JONES LLC | — -27.7K (-100.0%) | — -68.8K (-100.0%) | 0.00% -0.062 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 65 | GROUPE LA FRANCAISE | — -357.0 (-100.0%) | — -751.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 66 | LPL FINANCIAL LLC | — -22.9K (-100.0%) | — -56.8K (-100.0%) | 0.00% -0.051 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 67 | VIRTU FINANCIAL LLC | — -10.3K (-100.0%) | — -26.0K (-100.0%) | 0.00% -0.023 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 68 | FORTITUDE FAMILY OFFICE, LLC | — -208.0 (-100.0%) | — -516.0 (-100.0%) | 0.00% -0.001 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 69 | CLEARSTEAD ADVISORS, LLC | — -131.0 (-100.0%) | — -325.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 70 | SG AMERICAS SECURITIES, LLC | — -16.6K (-100.0%) | — -41.0K (-100.0%) | 0.00% -0.037 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 71 | SRS CAPITAL ADVISORS, INC. | — -1.6K (-100.0%) | — -3.8K (-100.0%) | 0.00% -0.004 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 72 | NISA INVESTMENT ADVISORS, LLC | — -205.0 (-100.0%) | — -508.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 73 | CREATIVE PLANNING | — -23.1K (-100.0%) | — -57.3K (-100.0%) | 0.00% -0.052 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 74 | GODSEY & GIBB, INC | — -10.0 (-100.0%) | — -25.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 15 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.03% | 391.3K | 0.60% |
| 2 | Vanguard Russell 2000 Growth ETF VTWG | 0.01% | 89.9K | 0.06% |
| 3 | Vanguard Russell 2000 ETF VTWO | 0.00% | 483.9K | 0.06% |
| 4 | Vanguard Extended Market ETF VXF | 0.00% | 988.9K | 0.05% |
| 5 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 22.9K | 0.17% |
| 6 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.7K | 0.17% |
| 7 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 8.3K | 0.03% |
| 8 | Vanguard Total Stock Market ETF VTI | 0.00% | 3.91M | 0.03% |
| 9 | Vanguard Russell 3000 ETF VTHR | 0.00% | 4.9K | 0.06% |
| 10 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 8.6K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
884.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+884,028
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-12 | Tendler Craig | Director | A-Award | A | Options (Right to Buy) | 156,240 | 1.29 | 201.5K | 156,240 | D | ↗ |
| 2026-02-12 | Ng George K | Director | A-Award | A | Options (Right to Buy) | 156,240 | 1.29 | 201.5K | 156,240 | D | ↗ |
| 2026-02-12 | MANUSO JAMES S J | Director | A-Award | A | Options (Right to Buy) | 156,240 | 1.29 | 201.5K | 156,240 | D | ↗ |
| 2026-02-12 | List Alan | Director | A-Award | A | Options (Right to Buy) | 156,240 | 1.29 | 201.5K | 156,240 | D | ↗ |
| 2026-02-12 | Hoffman Robert E. | Director | A-Award | A | Options (Right to Buy) | 156,240 | 1.29 | 201.5K | 156,240 | D | ↗ |
| 2026-01-06 | Dearborn Dan | Officer | A-Award | A | Options (Right to Buy) | 273,696 | 0.73 | 199.8K | 273,696 | D | ↗ |
| 2026-01-06 | Bianco James A. | Director / Officer | A-Award | A | Options (Right to Buy) | 610,332 | 0.73 | 445.5K | 610,332 | D | ↗ |
| 2025-12-12 | Dearborn Dan | Officer | A-Award | A | Options (Right to Buy) | 1,531,367 | 1.02 | 1.56M | 1,531,367 | D | ↗ |
| 2025-12-12 | Bianco James A. | Director / Officer | A-Award | A | Options (Right to Buy) | 3,414,891 | 1.02 | 3.48M | 3,414,891 | D | ↗ |
| 2025-03-10 | Tendler Craig | Director | A-Award | A | Options (Right to Buy) | 151,883 | 1.88 | 285.5K | 151,883 | D | ↗ |
| 2025-01-02 | Ng George K | Director | A-Award | A | Options (Right to Buy) | 51,275 | 4.11 | 210.7K | 51,275 | D | ↗ |
| 2025-01-02 | MANUSO JAMES S J | Director | A-Award | A | Options (Right to Buy) | 59,590 | 4.11 | 244.9K | 59,590 | D | ↗ |
| 2025-01-02 | List Alan | Director | A-Award | A | Options (Right to Buy) | 51,275 | 4.11 | 210.7K | 51,275 | D | ↗ |
| 2025-01-02 | Hoffman Robert E. | Director | A-Award | A | Options (Right to Buy) | 51,275 | 4.11 | 210.7K | 51,275 | D | ↗ |
| 2024-11-12 | Dearborn Dan | Officer | A-Award | A | Options (Right to Buy) | 489,848 | 4.94 | 2.42M | 489,848 | D | ↗ |
| 2024-11-12 | Bianco James A. | Director / Officer | A-Award | A | Options (Right to Buy) | 1,065,990 | 4.94 | 5.27M | 1,065,990 | D | ↗ |
Executive team
Top executives
Shares Outstanding
63.68M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| James A. Bianco | President, Chief Executive Officer & Director | 1M | — |
| Dan Dearborn | Executive Vice President of Finance & Chief Financial Officer | 544.0K | male |
| Bertrand Le Bourdonnec | Executive Vice President, Head of Drug Discovery, Early Development, & Program Management | — | male |
| Amanda Garofalo | Senior Vice President of Clinical Operations | — | female |
| Michael Krsulich | Head of Quality Assurance | — | male |
| Michael Lawman | Co-Founder | — | male |
| Patricia Lawman | Co-Founder | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HURA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
